SciNeuro and Novartis Strike US$1.7 Billion Deal, Raising Fresh Hope for Alzheimer’s Treatment

A major partnership between China’s SciNeuro Pharmaceuticals and Swiss drugmaker Novartis has raised renewed hopes for progress in the fight against Alzheimer’s disease, a condition that affects an estimated 55 million people worldwide and poses a growing burden on global health systems and